A detailed history of Oliver Luxxe Assets LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Oliver Luxxe Assets LLC holds 10,284 shares of CRL stock, worth $1.73 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
10,284
Holding current value
$1.73 Million
% of portfolio
0.29%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026

BUY
$167.03 - $197.04 $1.72 Million - $2.03 Million
10,284 New
10,284 $1.73 Million
Q1 2021

Apr 29, 2021

SELL
$249.67 - $299.48 $1.33 Million - $1.59 Million
-5,317 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$222.0 - $252.62 $844,044 - $960,461
3,802 Added 250.96%
5,317 $1.47 Million
Q3 2020

Oct 20, 2020

SELL
$175.56 - $226.45 $2,106 - $2,717
-12 Reduced 0.79%
1,515 $343,000
Q1 2020

Apr 21, 2020

BUY
$98.9 - $178.34 $151,020 - $272,325
1,527 New
1,527 $216,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Oliver Luxxe Assets LLC Portfolio

Follow Oliver Luxxe Assets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.